Contribution of PET in the detection of liver metastases from pancreatic tumours
- PMID: 10210345
- DOI: 10.1016/s0009-9260(99)91160-1
Contribution of PET in the detection of liver metastases from pancreatic tumours
Abstract
Aim: Although uptake of 2-deoxy-2-[fluorine-18]fluoro-D-glucose (FDG) in the liver is basically high, metastatic liver tumours are known to be positive on positron emission tomography (PET). The purpose of this study is to evaluate the diagnostic accuracy of FDG-PET in detecting hepatic metastases from pancreatic cancer.
Methods: Thirty-four patients with histologically proven malignant tumours of the pancreas underwent FDG-PET, computed tomography (CT) and transabdominal ultrasound (US). The findings of PET, CT and US were compared with the histopathologic findings at surgery or with clinical follow-up and the diagnostic accuracy of PET was evaluated.
Results: PET showed 28 regions of high FDG uptake (SUV = 3.3-9.1) in 13 patients. Twenty-six foci were metastatic lesions confirmed by surgery (n = 11), clinical follow-up (n = 10) or autopsy (n = 5). FDG-PET accurately differentiated seven metastatic lesions from cysts when the diagnosis by US or CT was unreliable because of the small size of the lesion. In two patients who had areas of high uptake in the liver, no metastases were detected by surgery. FDG-PET showed no areas of increased uptake in 21 patients. Surgery revealed no metastatic lesions in the liver in 20 of 21 patients, but a liver metastasis was found at surgery in one patient. The diagnostic accuracy of FDG-PET was 90%, which was comparable with that of US or CT.
Conclusion: Our data suggest that PET is reliable in detecting liver, metastases from pancreatic cancer.
Similar articles
-
Detection of liver metastases from pancreatic cancer using FDG PET.J Nucl Med. 1999 Feb;40(2):250-5. J Nucl Med. 1999. PMID: 10025831
-
Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.ANZ J Surg. 2012 Mar;82(3):140-4. doi: 10.1111/j.1445-2197.2011.05972.x. Epub 2012 Jan 17. ANZ J Surg. 2012. PMID: 22510123
-
More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003
-
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.Abdom Imaging. 2012 Dec;37(6):983-1003. doi: 10.1007/s00261-012-9845-y. Abdom Imaging. 2012. PMID: 22527152 Review.
-
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.Ann Surg. 1999 May;229(5):729-37; discussion 737-8. doi: 10.1097/00000658-199905000-00016. Ann Surg. 1999. PMID: 10235532 Free PMC article. Review.
Cited by
-
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer.World J Surg Oncol. 2012 May 4;10:77. doi: 10.1186/1477-7819-10-77. World J Surg Oncol. 2012. PMID: 22559838 Free PMC article.
-
The role of transabdominal ultrasonography, helical computed tomography, and magnetic resonance cholangiopancreatography in diagnosis and management of pancreatic disease.Curr Gastroenterol Rep. 2000 Apr;2(2):120-4. doi: 10.1007/s11894-000-0095-8. Curr Gastroenterol Rep. 2000. PMID: 10981013 Review.
-
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.Cochrane Database Syst Rev. 2016 Sep 15;9(9):CD011515. doi: 10.1002/14651858.CD011515.pub2. Cochrane Database Syst Rev. 2016. PMID: 27631326 Free PMC article. Review.
-
State-of-the-art PET/CT of the pancreas: current role and emerging indications.Radiographics. 2012 Jul-Aug;32(4):1133-58; discussion 1158-60. doi: 10.1148/rg.324115143. Radiographics. 2012. PMID: 22786999 Free PMC article.
-
FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis.World J Gastroenterol. 2013 Aug 7;19(29):4808-17. doi: 10.3748/wjg.v19.i29.4808. World J Gastroenterol. 2013. PMID: 23922481 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical